Drug Compliance a Major Issue for Psych Patients
Compliance is a vital part of managing mental health issues, considering the widespread use of psychiatric medications in the U.S.
antipsychotics
FDA Approves First Monthly Atypical Antipsychotic for Schizophrenia
The U.S. Food and Drug Administration has approved Janssen Pharmaceuticals’ Invega Sustenna for acute and maintenance treatment of schizophrenia.